Discovery, mechanism and metabolism studies of 2, 3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy - Chen, W; Guo, N; Qi, M (Eur J Med Chem, 2017)